This legislation, known as the Safe Step Act, amends the Employee Retirement Income Security Act of 1974 (ERISA) to mandate that group health plans and health insurance issuers implement a clear, prompt, and transparent exceptions process for medication step therapy protocols. This process enables participants, beneficiaries, or their prescribing healthcare providers to request coverage for a non-preferred drug if the standard step therapy sequence is not medically appropriate. The bill outlines specific circumstances under which an exception must be granted, ensuring patients are not unduly delayed in accessing necessary treatments. Key circumstances requiring an exception include when prior treatments have been ineffective , when delaying effective treatment would lead to severe or irreversible consequences , or when required treatments are contraindicated or likely to cause adverse reactions. An exception must also be granted if treatments prevent a patient from achieving functional ability or if the patient is stable on the requested drug and previously approved for it. The process mandates standardized forms, clear criteria, and expedited review for urgent cases, with decisions required within 72 hours for standard requests and 24 hours for urgent ones. If an exception is granted, coverage for the requested drug must remain in effect for at least one year. The bill also establishes annual reporting requirements for plans and issuers to the Secretary, detailing the number of exception requests, approvals, denials, and reasons, broken down by specific criteria. The Secretary will then compile and submit a summary and analysis of this data to Congress annually, promoting transparency and oversight of step therapy practices.